The role of opioid analgesics in rheumatoid disease in the elderly population

Drugs and Aging

Volumn 20, Issue 8, 2003, Pages 571-583

  Griessinger, Norbert ^a   Sittl, Reinhard ^b   Jost, Robert ^c   Schaefer, Michael ^b   Likar, Rudolf ^c  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c GENERAL HOSPITAL KLAGENFURT   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; BENZATROPINE; BUPRENORPHINE; CELECOXIB; CODEINE; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; DIPYRONE; FENTANYL; HYDROMORPHONE; METHOTREXATE; MORPHINE; NAPROXEN; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OXYCODONE; PARACETAMOL; PLACEBO; ROFECOXIB; TRAMADOL; TUMOR NECROSIS FACTOR ALPHA;

AGRANULOCYTOSIS; ANALGESIC ACTIVITY; ANAPHYLAXIS; CARDIOVASCULAR DISEASE; CHRONIC PAIN; CLINICAL TRIAL; COMORBIDITY; CONFUSION; CONSTIPATION; DRUG CHOICE; DRUG EFFICACY; ELDERLY CARE; GASTROINTESTINAL SYMPTOM; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; MICTURITION DISORDER; MYALGIA; MYOFASCIAL PAIN; NAUSEA; OSTEOARTHRITIS; PATIENT COMPLIANCE; PATIENT EDUCATION; PHARMACODYNAMICS; POLYPHARMACY; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; RISK BENEFIT ANALYSIS; SEDATION; SIDE EFFECT; VERTIGO; VOMITING;

EID: 0037715237     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200320080-00003     Document Type: Review

References (85)

1. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24
2. Anderson KO, Bradley LA, Turner RA, et al. Pain behavior of rheumatoid arthritis patients enrolled in experimental drug trials. Arthritis Care Res 1994; 7: 64-8
3. Skevington S. Psychological aspects of pain in rheumatoid arthritis: a review. Soc Sci Med 1986; 23: 567-75
4. Buckelew SP, Parker JC. Coping with arthritis pain: a review of the literature. Arthritis Care Res 1989; 2: 136-45
5. Creamer P, Hochberg MC. Osteoarthritis. Lancet 1997; 350: 503-8
6. Lawrence RC, Helmick CG, Arnett FC, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998; 41 (5): 778-99
7. Felson DT, Zhang Y. An update on the epidemiology of knee and hip osteoarthritis with a view of prevention. Arthritis Rheum 1998; 41 (8): 1343-55
8. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 update. Arthritis Rheum 2002; 46 (2): 328-46
9. Johnson AG, Day RO. The problems and pitfalls of NSAID therapy in the elderly (Part 1). Drugs Aging 1991; 1 (2): 130-43
10. Wolfe MM, Lichtenstein D, Singh G. Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs. N Engl J Med 1999; 340: 1888-99
11. Singh G, Triadafilopoulus G. Epidemiology of NSAID-induced gastrointestinal complications. J Rheumatol 1999; 26 Suppl. 56: 18-24
12. Tramer MR, Moore RA, Reynolds DJ, et al. Quantitative estimation of rare adverse events which follow biological progression: a new model applied to chronic NSAID use. Pain 2000; 85 (1-2): 169-82
13. Griffin MR, Piper JM, Daugherty JR, et al. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991; 114 (4): 257-63
14. Griffin MR. Epidemiology of nonsteroidal anti-inflammatory drug-associated gastrointestinal injury. Am J Med 1998; 104 (3A): 23S-9S
15. Piper JM, Ray WA, Daugherty JR, et al. Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs. Ann Intern Med 1991; 114 (9): 753-40
16. Griffin MR, Yared A, Ray WA. Nonsteroidal anti-inflammatory drugs and acute renal failure in elderly persons. Am J Epidemiol 2000; 151 (5): 488-96
17. Page J, Henry D. Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an under-recognized public health problem. Arch Intern Med 2000; 160 (6): 777-84
18. Heerdink ER, Leufkens HG, Herings RM, et al. NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics. Arch Intern Med 1998; 158 (10): 1108-12
19. Silverstein FE, Faich G, Goldstein JL, et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis. The class study: a randomized controlled trial. JAMA 2000; 284: 1247-55
20. Bombardier C, Laine L, Reicin A, et al. Comparison of upper gastrotintestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med 2000; 343: 1520-8
21. Whelton A, Fort JG, Puma JA, et al. Cyclooxygenase-2-specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients. Am J Ther 2001; 8 (2): 85-95
22. Swan SK, Rudy DW, Lasseter KC, et al. Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet: a randomized, controlled trial. Ann Intern Med 2000; 133 (1): 1-9
23. Johnson AG, Nguyen TV, Day RO. Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med 1994; 121 (4): 289-300
24. Wolfe F, Zhao S, Lane N. Preference for nonsteroidal anti-inflammatory drugs over acetaminophen by rheumatic disease patients: a survey of 1799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia. Arthritis Rheum 2000; 43 (2): 378-85
25. Portenoy RK. Chronic opioid therapy in nonmalignant pain. J Pain Symptom Manage 1990; 5 (1 Suppl.): 46-62
26. Schug SA. Opioids for chronic noncancer pain. Pain Clinical Updates IASP 1995; III (3): 1-7
27. Graven S, de Vet HCW, van Kleef M, et al. Opioids in chronic nonmalignant pain: a criteria-based review of the literature. In: Devor M, Roubotham MC, Wiesnfeld-Hallin, editors. Proceedings of the 9th World Congress on Pain; 1999; Vienna, Austria. Seattle (WA): IASP Press, 2000: 965-72
28. Stein C. What is wrong with opioids in chronic pain? Curr Opin Anaesthesiol 2000; 13: 557-9
29. Roth SH. Arthritis therapy: a better time, a better day [editorial]. Rheumatology 2001; 40: 603-6
30. American Geriatrics Society Panel on Chronic Pain in Older Persons. Clinical practice guidelines: the management of chronic pain in older persons. J Am Geriatr Soc 1998; 46 (5): 635-51
31. Ferrell BR, Ferrell BA, editors. Pain in the elderly. Seattle (WA): IASP Press, 1996
32. Gagliese L, Melzack R. Chronic pain in elderly people. Pain 1997; 70 (1): 3-14
33. Gloth FM. Pain management in older adults: prevention and treatment. J Am Geriatr Soc 2001; 49 (2): 188-99
34. Weiner DK. Improving pain management for older adults: an urgent agenda for the educator, investigator, and practitioner. Pain 2002; 97 (1-2): 1-4
35. Bernabei R, Gambassi G, Lapane K, et al. Management of pain in elderly patients with cancer. SAGE Study Group: systematic assessment of geriatric drug use via epidemiology. JAMA 1998; 279 (23): 1877-82
36. Cleeland CS, Gonin R, Hatfield AK, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 1994; 330 (9): 592-6
37. Harkins SW, Price DD. Assessment of pain in the elderly. In: Turk DC, Melzack R, editors. Handbook of pain assessment: New York: Guilford. 1992: 315-31
38. Wright GE, Parker JC, Smarr KL, et al. Age, depressive symptoms, and rheumatoid arthritis. Arthritis Rheum 1998; 41: 298-305
39. Davis GC, Cortex C, Rubin BR. Pain management in the older adult with rheumatoid arthritis or osteoarthritis. Arthritis Care Res 1990; 3 (3): 127-31
40. Gibson SJ, Farrell MJ, Katz B, et al. Multidisciplinary management of chronic non-malignant pain on older adults. In: Ferrell BR, Ferrell BA, editors. Pain in the elderly. Seattle (WA): IASP Press, 1996: 91-99
41. Ross MM, Crook J. Elderly recipients of home nursing services: pain, disability and functional competence. J Adv Nurs 1998; 27 (6): 1117-26
42. Watkins KW, Shifren K, Park DC, et al. Age, pain and coping with rheumatoid arthritis. Pain 1999; 82: 217-28
43. Macintyre PE, Jarvis DA. Age is the best predictor of post-operative morphine requirements. Pain 1995; 64: 357-64
44. Kaiko RF. Age and morphine analgesia in cancer patients with postoperative pain. Clin Pharmacol Ther 1980; 28: 823-6
45. Bentley JB, Borel JD, Nenad Jr RE, et al. Age and fentanyl pharmacokinetics. Anesth Analg 1982; 61 (12): 968-71
46. Scott JC, Stanski DR. Decreased fentanyl and alfentanil dose requirements with age: a simultaneous pharmacokinetic and pharmacodynamic evaluation. J Pharmacol Exp Ther 1987; 240: 159-66
47. Bugeja G, Kumar A, Banerjee AK. Exclusion of elderly people from clinical research: a descriptive study of published reports. BMJ 1997; 315 (7115): 1059
48. Forman WB, Stratton M. Current approaches to chronic pain in older patients. Geriatrics 1991; 46: 47-52
49. Portenoy RK, Farkash A. Practical management of non-malignant pain in the elderly. Geriatrics 1988; 43: 29-47
50. Bellville JW, Forrest WH, Miller E, et al. Influence of age on pain relief from analgesics. JAMA 1971; 217: 1835-41
51. Loick G, Radbruch L, Sabatowski R, et al. Morphine close and side effects: a comparison of older and younger patients with tumour pain [in German]. Dtsch Med Wochenschr 2000 Oct 13; 125 (41): 1216-21
52. Portenoy RK. Optimal pain control in elderly cancer patients. Geriatrics 1987; 42: 33-44
53. Vigano A, Buera E, Suarez-Almazor ME. Age, pain intensity, and opioid dose in patients with advanced cancer. Cancer 1998; 83: 1244-50
54. Ruoff GE. Slowing the initial titration rate of tramadol improves tolerability. Pharmacotherapy 1999; 19 (1): 88-93
55. Evans PJS. Opioids for chronic musculoskeletal pain. In: Kalso E, McQuay JH, Wiesenfeld-Hallin Z, editors. Opioid sensitivity of chronic noncancer pain: progress in pain research and management. Vol. 14. Seattle (WA): IASP Press, 1999: 349-65
56. Schnitzer TJ, Kamin M, Olson WH. Tramadol allows reduction of naproxen dose among patients with naproxen-responsive osteoarthritis pain: a randomized, double-blind, placebo-controlled study. Arthritis Rheum 1999; 42 (7): 1370-7
57. Moulin DE, Iezzi A, Amireh R, et al. Randomized trial of oral morphine for chronic non-cancer pain. Lancet 1996; 347 (8995): 143-7
58. Arkinstall W, Sandler A, Goughnour B, et al. Efficacy of controlled-release codeine in chronic non-malignant pain: a randomized, placebo-controlled clinical trial. Pain 1995; 62 (2): 169-78
59. Caldwell JR, Hale ME, Boyd RE, et al. Treatment of osteoarthritis pain with controlled release oxycodone or fixed combination oxycodone plus acetaminophen added to nonsteroidal anti-inflammatory drugs: a double-blind, randomized, multicenter, placebo controlled trial. J Rheumatol 1999; 26 (4): 862-9
60. Peloso PM, Bellamy N, Bensen W, et al. Double blind randomize placebo control trial of controlled release codeine in the treatment of osteoarthritis of the hip or knee. J Rheumatol 2000; 27 (3): 764-71
61. Roth SH, Fleischmann RM, Burch FX, et al. Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluation. Arch Intern Med. 2000; 160 (6): 853-60
62. The use of opioids for the treatment of chronic pain: a consensus statement from the American Academy of Pain Medicine and the American Pain Society. Clin J Pain 1997; 13: 6-8
63. Ytterberg SR, Mahowald ML, Woods SR. Codeine and oxycodone use in patients with chronic rheumatic disease pain. Arthritis Rheum 1998; 41 (9): 1603-12
64. Gelfand SG. Opioids and rheumatic disease pain: comment on the article by Ytterberg, et al. Arthritis Rheum 1999; 42 (4): 830-1
65. Watson CP, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology 1998; 50 (6): 1837-41
66. McQuay H. Opioids in chronic non-malignant pain. BMJ 2001; 322 (7295): 1134-5
67. American Society of Anesthesiologists Task Force on Pain Management, Chronic Pain Section. Practice guidelines for chronic pain management. Anesthesiology 1997; 86: 995-1004
68. Gotzsche PC, Johansen HK. Short-term low-dose corticosteroids vs placebo and nonsteroidal antiinflammatory drugs in rheuamatoid arthritis. Cochrane Database Syst Rev 2003; (1): CD000189
69. WHO. Cancer pain relief. 2nd ed. Geneva: WHO, 1996
70. Fishman SM, Bandman TB, Edwards A, et al. The opioid contract in the management of chronic pain. J Pain Symptom Manage 1999; 18: 27-37
71. Roth SH. Efficacy and safety of tramadol HCL in breakthrough musculoskeletal pain attributed to osteoarthritis. J Rheumatol 1998; 25 (7): 1358-63
72. Pavelka K, Peliskova Z, Stehlikova H, et al. Intraindividual differences in pain relief and functional improvement in osteoarthritis with diclofenac or tramadol. Clin Drug Invest 1998; 16: 421-9
73. Wilder-Smith CH, Hill L, Spargo K, et al. Treatment of severe pain from osteoarthritis with slow-release tramadol or dihydrocodeine in combination with NSAIDs: a randomized study comparing analgesia, antinociception and gastrointestinal effects. Pain 2001; 91 (1-2): 23-31
74. Allan L, Hays H, Jensen NH, et al. Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain. BMJ 2001; 322 (7295): 1154-8
75. Schaefer M. Peripheral opioid analgesia: from experimental to clinical studies. Curr Opin Anaesthesiol 1999; 12: 603-11
76. Stein C. The control of pain in peripheral tissue by opioids. N Engl J Med 1995; 332 (25): 1685-90
77. Zhou L, Zhang Q, Stein C, et al. Contribution of opioid receptors on primary afferent versus sympathetic neurons to peripheral opioid analgesia. J Pharmacol Exp Ther 1998; 286 (2): 1000-6
78. Schaefer M, Imai Y, Uhl GR, et al. Inflammation enhances peripheral mu-opioid receptor-mediated analgesia, but not mu-opioid receptor transcription in dorsal root ganglia. Eur J Pharmaol 1995; 279 (2-3): 165-9
79. Gupta A, Bodin L, Holmström B, et al. A systematic review of the peripheral analgesic effects of intraarticular morphine. Anesth Analg 2001; 93 (9): 761-70
80. Likar R, Schaefer M, Paulak F, et al. Intraarticular morphine analgesia in chronic pain patients with osteoarthritis. Anesth Analg 1997; 84 (6): 1313-7
81. Stein A, Yassoouridis A, Szopko C, et al. Intraarticular morphine versus dexamethasone in chronic arthritis. Pain 1999; 83 (3): 525-32
82. Stein C, Pfluger M, Yassouridis A, et al. No tolerance to peripheral morphine analgesia in presence of opioid expression in inflamed synovia. J Clin Invest 1996; 98 (3): 793-9
83. Rozental JD, Sculco TP. Intra-articular corticosteroids: an updated overview. Am J Orthop 2000; 29: 18-23
84. Barber A, Bartoszyk GD, Bender HM, et al. A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753. Br J Pharmacol 1994; 113 (4): 1317-27
85. Walker JS. Anti-inflammatory effects of opioids. Adv Exp Med Biol 2003; 521: 148-60